Ovid Therapeutics (OVID) Capital Expenditures Growth (1y) (2017 - 2024)
Ovid Therapeutics (OVID) Capital Expenditures Growth (1y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ovid Therapeutics |
311.83 Mn |
156.31 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-300.00% |
| Sep 30, 2024 |
175.90% |
| Jun 30, 2024 |
-64.58% |
| Mar 31, 2024 |
35.71% |
| Dec 31, 2023 |
-98.66% |
| Sep 30, 2023 |
90.05% |
| Jun 30, 2023 |
-90.91% |
| Mar 31, 2023 |
-53.69% |
| Sep 30, 2022 |
-13,546.77% |
| Jun 30, 2022 |
9,067.26% |
| Sep 30, 2021 |
-102.94% |
| Jun 30, 2021 |
106.34% |
| Dec 31, 2020 |
-73.09% |
| Sep 30, 2020 |
56,040.81% |
| Jun 30, 2020 |
-14,696.06% |
| Mar 31, 2020 |
3,961.12% |
| Dec 31, 2019 |
1,002.13% |
| Sep 30, 2019 |
100.28% |
| Jun 30, 2019 |
-99.25% |
| Mar 31, 2019 |
-38.66% |
